Concepedia

Theo Nicholaou

TN

4

Publications

427

Citations

4

H-Index

2007

Active since

Affiliations

Ludwig Cancer Research(Current)

Austin Health

Peter MacCallum Cancer Centre

Ludwig Cancer Research

Theo Nicholaou is an author at Ludwig Cancer Research specializing in vaccine development, tumor immunity, and t cell immunity.

Top concepts

Publications per year

2007–2011

4

Publications

4

An Open-Label, Two-Arm, Phase I Trial of Recombinant Human Interleukin-21 in Patients with Metastatic Melanoma

Ian D. Davis, Birte K. Skrumsager, Jonathan Cebon et al. · Clinical Cancer Research · 2007 · 164 citations · Full text

Regulatory T-Cell–Mediated Attenuation of T-Cell Responses to the NY-ESO-1 ISCOMATRIX Vaccine in Patients with Advanced Malignant Melanoma

Theo Nicholaou, Lisa M. Ebert, Ian D. Davis et al. · Clinical Cancer Research · 2009 · 118 citations · Full text

Melan-A–specific Cytotoxic T Cells Are Associated with Tumor Regression and Autoimmunity Following Treatment with Anti-CTLA-4

Oliver Klein, Lisa M. Ebert, Theo Nicholaou et al. · Clinical Cancer Research · 2009 · 97 citations · Full text

Immunoediting and persistence of antigen-specific immunity in patients who have previously been vaccinated with NY-ESO-1 protein formulated in ISCOMATRIX™

Theo Nicholaou, Weisan Chen, Ian D. Davis et al. · Cancer Immunology Immunotherapy · 2011 · 48 citations · Full text

, , +14

Rows per page

1–4 of 4